Research Topics
| Sylvie BonvalotSummaryAffiliation: Institut Gustave Roussy Country: France Publications
| Collaborators
|
Detail Information
Publications
[Soft tissue sarcoma : improved quality of life with new surgical approaches]Sylvie Bonvalot
Departement de Chirurgie Generale, Comité Sarcomes, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Bull Cancer 89:1045-52. 2002..This is a review of diagnostic and therapeutic improvements which have allowed quality of life of patients with soft tissue sarcoma...
[Management of recurrent soft tissue sarcoma of the retroperitoneum]Sylvie Bonvalot
Departement de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
Bull Cancer 91:845-52. 2004..Adequate management at the time of primary presentation is likely to afford the best chance for long-term survival...
Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local controlSylvie Bonvalot
Department of Surgery, Public Health, and Medical Oncology, Institut Gustave Roussy, Villejuif, France
J Clin Oncol 27:31-7. 2009..To define the optimal initial management and the best extent of surgery that would optimize margins on primary retroperitoneal sarcomas (RPS)...
The treatment of desmoid tumors: a stepwise clinical approachS Bonvalot
Department of Surgery, Institut Gustave Roussy, Villejuif, France
Ann Oncol 23:x158-66. 2012....
Hyperthermic pelvic perfusion with tumor necrosis factor-α for locally advanced cancers: encouraging results of a phase II studySylvie Bonvalot
Department of Surgery, Institut Gustave Roussy, Villejuif Cedex, France
Ann Surg 255:281-6. 2012..To assess the efficacy of isolated pelvic perfusion (IPP) with tumor necrosis factor (TNF)-α and melphalan in patients with locally advanced cancers in the pelvic and groin area requiring mutilating surgery...
[Diagnosis and treatment of gastrointestinal stromal tumours]Sylvie Bonvalot
Departement de Chirurgie, Institut Gustave Roussy, 94805 Villejuif
Rev Prat 56:359-67. 2006..New blockers of the tyrosine-kinase activity are currently in development in cases of resistance...
[Surgical management of GIST in the era of Gleevec]S Bonvalot
Departement de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Ann Chir 130:144-51. 2005..Surgery is being evaluated in the other responding patients. The majority of responses being limited to partial responses, best indications of surgery are when complete resection may be expected (< 10%)...
[An update of the surgical indications for gastrointestinal stromal tumors]S Bonvalot
Departement de Chirurgie, Institut Gustave Roussy, Villejuif
J Chir (Paris) 145:6S8-11. 2008..A phase 3 EORTC study will start and will randomise this secondary surgery after 6 to 12 months of imatinib in responding patients...
[Surgery of retroperitoneal sarcomas]S Bonvalot
Departement de Chirurgie, Comité Sarcome, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
Cancer Radiother 10:41-9. 2006..The 5-year probability of local control is approximately 50%. The role of adjuvant therapy is evolving and at present should not be used outside the investigational setting...
Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?S Bonvalot
Department of Surgery, Institut Gustave Roussy, Villejuif, France
Ann Oncol 16:1061-8. 2005..The optimal dose of TNF-alpha delivered by isolated limb perfusion (ILP) in patients with locally advanced soft tissue sarcoma is still unknown...
Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosisS Bonvalot
Department of Surgery, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Eur J Surg Oncol 31:917-23. 2005..In order to decrease loco-regional relapse after complete resection of peritoneal sarcomatosis (PS), the role of intraperitoneal chemotherapy (IPEC) was prospectively evaluated...
[Function preserving surgery of limb sarcomas: history and improvements]S Bonvalot
Departement de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
Cancer Radiother 10:416-24. 2006..Efficacy and safety of low-dose TNFalpha could greatly facilitate ILP procedures in the near future...
[Surgical news of soft tissue sarcomas, fibromatosis and GIST]S Bonvalot
Institut Gustave Roussy, Departement de Chirurgie, 39, rue Camille Desmoulins, 94805 Villejuif, France
Bull Cancer 97:645-56. 2010..An ongoing phase III EORTC randomises this secondary surgery after 6 to 12 months of imatinib in responding patients...
Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib eraS Bonvalot
Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France
Ann Surg Oncol 13:1596-603. 2006..The objective of this retrospective study was to evaluate the feasibility and benefit of this secondary surgery...
[What is new in the local approach of limb sarcomas and desmoid tumours?]S Bonvalot
Comité Sarcomes, Departement de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Cancer Radiother 14:455-9. 2010..Additional study of the molecular determinants of desmoid behaviour is needed to guide treatment...
Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patientsS Bonvalot
Department of Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
Eur J Surg Oncol 34:462-8. 2008..To evaluate the impact of surgery as first-line treatment on event-free survival (EFS) of primary aggressive fibromatosis...
Pressure-suit combined with pelvic stop-flow: a feasibility study in a bovine modelS Bonvalot
Department of Surgery, Institut Gustave Roussy, 94805 Villejuif, France
Eur J Surg Oncol 33:114-8. 2007..Isolated pelvic perfusion exposes tissue to high drug doses and may benefit patients with advanced malignancy. However, leakage is a limit to this technique...
[Free-flap reconstruction of locally advanced soft tissue sarcomas]S Bonvalot
Departement de Chirurgie Oncologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Ann Chir 126:308-13. 2001..The aim of this retrospective study was to assess the advantages of free-lap reconstruction in locally advanced soft tissue sarcomas...
[Pelvic perfusion for localy advanced tumors]Sylvie Bonvalot
Departement de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
Bull Cancer 96:103-9. 2009..A randomized study will start soon...
Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patientsDaniel Vanel
Department of Radiology, Institut Gustave Roussy, rue Camille Desmoulins, 94800 Villejuif, France
Eur J Radiol 54:118-23. 2005..To prospectively analyze the evolution of hepatic and peritoneal unresectable metastases from gastrointestinal stromal tumors (GIST) under imatinib mesylate, a new targeted treatment, which induces changes in lesion structure...
[Locally advanced soft-tissue sarcomas. An innovating triad to avoid amputation: isolated limb perfusion, TNFalpha, and free microsurgical flap]Michel A Germain
Departement de Chirurgie Oncologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, F 94805 Villejuif Cedex
Bull Acad Natl Med 194:51-65; discussion 65-7. 2010..Isolated limb perfusion and free flap reconstruction permitted more extensive tumor excision. Amputation was avoided in 78% of our 37 patients, and early postoperative radiotherapy was possible in 25 cases...
Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!)Mylene Mabille
Department of Radiology, Institut Gustave Roussy, Villejuif, France
Eur J Radiol 69:204-8. 2009..To define computed tomography (CT) criteria for evaluating the response of patients with gastrointestinal stromal tumors (GIST) who are receiving Imatinib (tyrosine-kinase inhibitor therapy)...
Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficientSylvie Bonvalot
Department of Surgery, Institut Gustave Roussy, Villejuif Cedex, France
Ann Surg Oncol 16:3350-7. 2009..The objective of the present study was to confirm these data on a larger sample size of locally advanced or recurrent extremity soft tissue sarcomas with low-dose TNF-alpha...
Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonographyNathalie Lassau
Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
AJR Am J Roentgenol 187:1267-73. 2006..The purpose of this study was to evaluate contrast-enhanced Doppler sonography with perfusion software as a predictor of early tumor response to imatinib (Glivec) in c-kit-positive gastrointestinal stromal tumors (GISTs)...
Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcomaOlivier Mir
Sarcoma Unit, Herault Ward, Department of Medicine, Institut Gustave Roussy, Université Paris 11, 39 rue Camille Desmoulins, Villejuif, France
Eur J Cancer 47:515-9. 2011..A sizeable population of elderly patients with STS is unfit for conventional doxorubicin- or ifosfamide-based chemotherapy. We assessed the feasibility of metronomic oral cyclophosphamide (CPM) in this population...
Doxorubicin and ifosfamide for high-grade sarcoma during pregnancyOlivier Mir
Department of Medicine, Sarcoma Unit, Herault Ward, Institut Gustave Roussy, Paris Sud University, 39, rue Camille Desmoulins, 94800 Villejuif Cedex, France
Cancer Chemother Pharmacol 69:357-67. 2012..Doxorubicin and ifosfamide are highly active drugs for the treatment of high-grade sarcomas, but little is known on the optimal management of young patients who develop such malignancies during pregnancy...
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)Axel Le Cesne
Institut Gustave Roussy, Villejuif, France
Eur J Cancer 46:1344-51. 2010..This phase II study evaluated masitinib as a first-line treatment of advanced GIST...
Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local controlSylvie Bonvalot
Department of Surgery, Institut Gustave Roussy, Villejuif, France
Ann Surg Oncol 17:1507-14. 2010..We sought to assess morbidity and mortality in primary retroperitoneal soft tissue sarcomas (RSTS) treated by a frontline aggressive surgical approach...
MR imaging in the evaluation of isolated limb perfusion: a prospective study of 18 casesDaniel Vanel
Department of Radiology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Skeletal Radiol 33:150-6. 2004....
[Place and technical aspects of external beam radiation therapy in the treatment of adult soft tissue sarcomas]Cécile Le Péchoux
Departement de Radiotherapie, Institut Gustave Roussy, 94805 Villejuif, France
Cancer Radiother 10:50-62. 2006..A randomized trial is warranted. Because of its rarity, and the risk of recurrence both local and metastatic, treatment should preferentially be discussed with a multimodality specialized approach...
[Retroperitoneal sarcomas imaging]François J Bidault
Service de Radiodiagnostic, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex
Bull Cancer 93:1167-74. 2006..The aim of this article is to expose imaging protocols and useful radiological signs, to show the core biopsy technique for diagnosis, to precise imaging key points before treatment and for survey...
Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?K Khanfir
Department of Radiotherapy, Institut Gustave Roussy, 94805 Villejuif, France
Eur J Cancer 39:1872-80. 2003....
[Focus on GIST management]M Tardieu
Institut Gustave Roussy, Departement de Medecine, 39, rue Camille Desmoulins, 94800 Villejuif Cedex, France
Bull Cancer 97:723-31. 2010....
[Clinical practice guidelines: 2006 update of recommendations for the radiotherapeutic management of patients with soft tissue sarcoma (sarcoma of the extremity, uterine sarcoma and retroperitoneal sarcoma]C Le Pechoux
Institut Gustave Roussy, Villejuif, France
Cancer Radiother 10:185-207. 2006..This work is based on the methodology developed in the "Standards, Options and Recommendations" (SOR) project...
Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcomaA Le Cesne
Institut Gustave Roussy, Villejuif, France
Drugs Today (Barc) 45:403-21. 2009....
Liposarcoma or lipoma: does genetics change classic imaging criteria?F Bidault
Department of Radiology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
Eur J Radiol 72:22-6. 2009..Cytogenetic and molecular genetic analyses contribute to the diagnosis and can be performed at the same time with a core biopsy...
Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: feasibility and preliminary resultsD Elias
Department of Oncologic Digestive Surgery, Institut Gustave Roussy, Cancer Center Hospital, Villejuif, France
Hepatogastroenterology 46:360-3. 1999..The purpose of this study is to report tolerance and preliminary results in patients with liver metastases synchronous to moderate PC, treated with hepatectomy, complete cytoreductive surgery, and IPIC...
Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma GroupE Stoeckle
Department of Surgery, Institut Bergonie, Bordeaux, France
Cancer 92:359-68. 2001..However, despite progress, surgery alone is rarely curative, and analysis of the causes of failures and of other prognostic factors are warranted to ascertain treatment orientations...
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trialA Le Cesne
Department of Medicine, Institut Gustave Roussy, 94805 Villejuif Cedex, France
J Clin Oncol 23:576-84. 2005..5 mg/m(2) as a 24-hour continuous infusion every 3 weeks in patients with pretreated advanced soft tissue sarcoma...
Prognostic factors after surgery of primary resectable gastrointestinal stromal tumoursT Aparicio
Department of Medicine, Institut Gustave Roussy, Villejuif, France
Eur J Surg Oncol 30:1098-103. 2004..A peri-tumoral resection confers a high risk of local recurrence and should be avoided. Lymphadenectomy is not systematic. Grade is the main prognostic factor for OS and can be a decision marker for adjuvant treatment with Gleevec...
p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-alpha and melphalanJ Muret
Department of AnesthesiaInstitut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Ann Oncol 19:793-800. 2008..The relationship between p53 status and response to TNF-alpha and melphalan in patients undergoing ILP is unknown...
Imatimid-induced bone marrow necrosis detected on MRI examination and mimicking bone metastasesD Vanel
Institut Gustave Roussy, Villejuif, France
Skeletal Radiol 36:895-8. 2007..Focal bone marrow abnormalities, detected on MRI examinations and mimicking bone metastases in patients who were otherwise responding, should be considered as probable bone marrow necrosis...
Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 casesN Lassau
Department of Medical Imaging, Surgery, Pathology and Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
Ann Oncol 16:1054-60. 2005....
IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?Amaury Paumier
Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
Radiother Oncol 99:73-8. 2011....
[Continued complete remission of Merkel cell carcinoma with in-transit metastasis after treatment with isolated limb perfusion regional chemotherapy]C Grandpeix
Service de Dermatologie, Institut Gustave Roussy, Villejuif, France
Ann Dermatol Venereol 133:700-3. 2006..Primitive cutaneous neuroendocrine carcinoma or Merkel cell carcinoma is a rare tumor. It may be large since diagnosis is frequently delayed. The usual treatment is extensive surgical removal and radiotherapy...
Unusual problems in breast cancer and a rare lung cancer case. Case 2. Aggressive fibromatosis of the chest wall arising near a breast prosthesisKaouthar Khanfir
Institut Gustave Roussy, Villejuif, France
J Clin Oncol 21:2216-8. 2003
[Pulmonary carcinosarcoma with jejunal metastasis: complete response to chemotherapy]F Saint-Georges
Département de médecine adulte, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
Rev Pneumol Clin 58:249-52. 2002..This rare case illustrates the potential for jejunal metastasis and complete response to chemotherapy, proven histologically at 33 months...
Spermatic cord sarcoma in adultsO Merimsky
Department of Medicine, Institut Gustav Roussy, Villejuif, France
Acta Oncol 38:635-8. 1999..5 months. Surgery was the primary treatment and the best salvage modality. The role of chemotherapy and radiation therapy as true adjuvant or post-salvage-surgery adjunctive treatments remains unclear...
Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 functionJane Muret
Unité INSERM U753, Institut de Cancerologie Gustave Roussy, Villejuif, France
PLoS ONE 7:e38808. 2012..Here we tested the ability of TNF-α to directly induce apoptosis of sarcoma cells. In addition, we investigated the impact of p53 in the regulation of such effect...
[Treatment of local recurrent melanomas by isolated limb perfusion: value of Doppler ultrasonography]P Hochedez
Service de Dermatologie, Institut Gustave Roussy (IGR, 39 rue Camille Desmoulins, 94805 Villejuif, France
J Radiol 84:597-603. 2003..CONCLUSION: Color Doppler US is highly effective for the follow-up of patients with recurrent melanoma of the limbs. It provides prognostic factors of treatment failure, which may lead to early modification of the treatment strategy...
High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease managementJ Domont
Sarcoma Committee, Institut Gustave Roussy, Villejuif, France
Br J Cancer 102:1032-6. 2010..There are no known molecular biomarkers of local recurrence. We searched for beta-catenin mutations in a European multicentre series of fibromatosis tumours to relate beta-catenin mutational status to disease outcome...
[The development of operating tables]M A Germain
Departement de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex
Ann Chir 131:162-6. 2006..Introduction of anaesthesia in 1846 and asepsis in 1870 have strongly allowed this development...
Management of gastrointestinal stromal tumors in the imatinib era: selected case studiesRobert S Benjamin
Sarcoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA
Oncologist 11:9-20. 2006..The management of GIST in these cases required a coordinated, multidisciplinary approach involving medical oncologists, diagnostic radiologists, gastroenterologists, surgeons, and pathologists...
[Recommendations for the management of GIST patients]Jean Yves Blay
Unité Inserm 590, Centre Leon Berard, 69008 Lyon
Bull Cancer 92:907-18. 2005..A national consensus meeting was therefore organized in order to identify the optimal management procedures for patients with GIST in localized and advanced stages...
[Neoadjuvant chemotherapy in sarcoma]Jean Yves Blay
Hôpital Edouard Herriot et Unité Inserm U590, Centre Leon Berard, 28, rue Laennec, 69008 Lyon
Bull Cancer 93:1093-8. 2006..In elderly and/or frail patients, conversely, single agent doxorubicin may be the preferred option...
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-upP G Casali
Department of Cancer Medicine, Istituto Nazionale dei Tumori, Milan, Italy
Ann Oncol 19:ii89-93. 2008
Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-upP G Casali
Department of Cancer Medicine, Istituto Nazionale dei Tumori, Milan, Italy
Ann Oncol 19:ii35-8. 2008
